We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+36.08%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+531.4%
AUM
$4.08B
AUM Growth
+$236M
Cap. Flow
-$708M
Cap. Flow %
-17.33%
Top 10 Hldgs %
19.32%
Holding
5,845
New
764
Increased
1,966
Reduced
2,392
Closed
665

Sector Composition

Rank Sector Weight
1 Miscellaneous 34.65%
2 Technology 23.8%
3 Financials 7.62%
4 Industrials 7.22%
5 Healthcare 6.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FLUX icon
4301
Flux Power
FLUX
$10M
$5.14K ﹤0.01%
5,949
+3,424
+136% +$3.64K
ILAG icon
4302
Intelligent Living
ILAG
$6.02M
$5.13K ﹤0.01%
1,500
+500
+50% +$1.79K
FTLF icon
4303
FitLife Brands
FTLF
$87M
$5.1K ﹤0.01%
463
-727
-61% -$7.34K
JZXN icon
4304
Jiuzi Holdings
JZXN
$58.2M
$5.1K ﹤0.01%
4,900
+2,900
+145% +$3.25K
CDT icon
4305
CDT Equity Inc
CDT
$1.1M
$5.09K ﹤0.01%
910
+899
+8,173% +$18.6K
SEAT icon
4306
Vivid Seats
SEAT
$41.6M
$5.07K ﹤0.01%
778
-6,598
-89% -$50.6K
TSAT icon
4307
Telesat
TSAT
$734M
$5.06K ﹤0.01%
100
-3,966
-98% -$192K
ICSH icon
4308
iShares Ultra Short Duration Bond Active ETF
ICSH
$8.9B
$5.06K ﹤0.01%
+100
New +$5.05K
BUDA
4309
Buda Juice Inc
BUDA
$89.9M
$5.05K ﹤0.01%
594
+253
+74% +$2.33K
QTI
4310
QT Imaging Holdings
QTI
$35.9M
$5.05K ﹤0.01%
1,240
-120
-9% -$667
BRLT icon
4311
Brilliant Earth
BRLT
$23.2M
$5.04K ﹤0.01%
+4,463
New +$5.68K
PARA
4312
Banzai International
PARA
$2.49M
$5.03K ﹤0.01%
+1,664
New +$11.1K
NNVC icon
4313
NanoViricides
NNVC
$36.8M
$5.03K ﹤0.01%
3,642
-3,274
-47% -$4.49K
TCBS icon
4314
Texas Community Bancshares
TCBS
$48.8M
$5.02K ﹤0.01%
+285
New +$4.87K
ATER icon
4315
Aterian
ATER
$11.9M
$5.01K ﹤0.01%
3,795
+2,329
+159% +$2.42K
SKIL icon
4316
Skillsoft
SKIL
$54.1M
$5.01K ﹤0.01%
967
-2,121
-69% -$14.1K
MIND icon
4317
MIND Technology
MIND
$39.4M
$4.99K ﹤0.01%
+1,057
New +$6.92K
SER icon
4318
Serina Therapeutics
SER
$53.1M
$4.99K ﹤0.01%
2,570
+1,727
+205% +$3.24K
DWTX
4319
Dogwood Therapeutics
DWTX
$46.2M
$4.98K ﹤0.01%
3,093
-4,974
-62% -$8.24K
DRMA icon
4320
Dermata Therapeutics
DRMA
$5.65M
$4.98K ﹤0.01%
3,860
+3,144
+439% +$3.96K
ICU icon
4321
SeaStar Medical
ICU
$15.1M
$4.98K ﹤0.01%
1,356
-39
-3% -$148
DGNX
4322
Diginex Ltd
DGNX
$39.3M
$4.97K ﹤0.01%
+3,361
New +$6.94K
INLX icon
4323
Intellinetics
INLX
$23.1M
$4.97K ﹤0.01%
903
+490
+119% +$3.28K
QTEX
4324
QTREX Quantum
QTEX
$52.1M
$4.96K ﹤0.01%
+3,441
New +$3.6K
PXLW icon
4325
Pixelworks
PXLW
$41.9M
$4.94K ﹤0.01%
793
-178
-18% -$1.08K

Similar funds

Tower Research Capital (TRC)'s Q2 2026 Portfolio in Review

As of Q2 2026, Tower Research Capital (TRC) held 5,845 positions worth $4.08B, up 6.1% from $3.85B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Tower Research Capital (TRC) withdrew a net $708M in Q2 2026, closing 665 positions and reducing 2,392 holdings. Its most notable exit was iShares MSCI USA Min Vol Factor ETF, an estimated $13M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 35% of assets, up from 29% a quarter earlier, followed by Technology and Financials.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Core S&P 500 ETF worth $84M.

  • Tower Research Capital (TRC)'s largest Q2 2026 buy was iShares Core S&P 500 ETF: 112,156 shares worth $84M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q2 2026, an estimated $130M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2026 reduction was Direxion Daily Semiconductor Bull 3X ETF, cutting an estimated $361M.
  • Tower Research Capital (TRC) fully exited iShares MSCI USA Min Vol Factor ETF in Q2 2026, selling an estimated $13M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 19% of its $4.08B portfolio in Q2 2026.
  • Tower Research Capital (TRC) opened 764 new positions and closed 665 in Q2 2026.
  • Tower Research Capital (TRC)'s portfolio value rose 6.1% quarter-over-quarter to $4.08B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.